A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

US stocks faced a decline on Wednesday after the Federal Reserve decided to leave interest rates unchanged, signaling a ...

“The Fed has shown an accommodative bias,” said Kevin Thozet, a member of the investment committee at Carmignac, who favors ...

Strong earnings, record shareholder returns and resilience amid falling interest rates were the catalysts behind European ...

The Fed will outline a rate decision Wednesday. Due to evidence of a strong U.S. economy, interest rates are widely expected to be kept on hold. Focus will center on any accompanying hints about ...

In normal circumstances, Trump’s influence would be limited because another president will replace him in four years. But ...

Not everyone is bullish looking ahead, however, with some — such as JPMorgan Chase CEO Jamie Dimon — suggesting markets could ...

President Trump has ambitions for a reordering of world commerce, with tariffs on items imported into the United States as a ...

Discover the Vanguard Mega Cap Value ETF (MGV) - a value-focused investment option offering low volatility and attractive ...

Better bank earnings and inflation readings sent bond and stock prices higher. Earnings and politics will likely have the ...

The risks of a broad implementation of tariffs have "likely increased," given recent reports that members of President Donald Trump's economic team are considering raising them by 2% to 5% per month, ...